Liver damage, common in COVID-19 as diagnosed by elevated liver enzymes ALT, AST, ALP, and GGT in the blood, [46], also leads to the release of arginase type I, contributing to arginine depletion and compounding the risk of thrombotic complications. Here, GPT is linked to COVID-19.